首页> 外文期刊>健康(英文) >Differences in Treatment of Schizoaffective Disorder and Schizophrenia in Real Clinical Practice in Slovakia
【24h】

Differences in Treatment of Schizoaffective Disorder and Schizophrenia in Real Clinical Practice in Slovakia

机译:斯洛伐克真正临床实践中脑疾病和精神分裂症治疗的差异

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Schizoaffective Disorder (SAD), similarly to schizophrenia, is a potentially chronic mental disorder that negatively affects the functioning of a patient. Various issues in everyday clinical practice often arise from its diagnostic and therapeutic uncertainty. To date, there is a lack of a well-defined therapeutic algorithm used to treat the simultaneously manifesting schizophrenic and affective components. The aim of this study was to compare the therapeutic approaches in schizophrenia and schizoaffective disorders to identify the need of different treatment strategy for these diseases. Methods: In a retrospective study, we evaluated the therapeutic algorithms used in all patients with SAD (n = 99) hospitalized at the Department of Psychiatry, Comenius University in Bratislava, Faculty of Medicine and University Hospital Bratislava throughout the year 2010 and compared them with the therapeutic procedures used in all schizophrenia patients hospitalized in the same year (n = 120). Results: We found similarities between the groups of patients with schizophrenia and SAD in the number, type and length of hospitalizations and general patient management. Differences were identified in terms of the spectrum of used pharmacotherapy. For the treatment of both mental disorders, atypical antipsychotics were used the most. In the treatment of schizophrenia, we found the most frequent use of combined antipsychotic therapy, meaning oral and long-acting injectable forms. Patients with SAD mostly received antipsychotic monotherapy, but its complex effects were supplemented with other psychotropic drugs, mostly mood-stabilizers and anxiolytics. Conclusion: The results of our study show similarities between schizophrenia and SAD in terms of health care utilization, despite the fact that SAD is generally considered to be a “milder” disorder. On the other hand, this study indicates differences in the spectrum of pharmacotherapy used.
机译:背景:与精神分裂症同样,脑疗法疾病(悲伤)是一种潜在的慢性精神障碍,其负面影响患者的功能。日常临床实践中的各种问题通常来自其诊断和治疗不确定性。迄今为止,缺乏定义明确的治疗算法,用于治疗同时表现出的精神分裂症和情感组分。本研究的目的是比较精神分裂症和SchizoAfcerive疾病的治疗方法,以确定这些疾病的不同治疗策略的需求。方法:在回顾性研究中,我们评估了在2010年的Bratislava,Bratislava的Bratislava Comenius大学的精神病学院住院治疗的所有患者的治疗性算法,在2010年的2010年,并将其与所有精神分裂症患者使用的治疗程序在同一年住院(n = 120)。结果:我们在住院的数量,类型和长度和一般患者管理中发现了精神分裂症患者组之间的相似之处。就二手药疗法的光谱确定了差异。为了治疗精神障碍,最多使用了非典型抗精神病药。在精神分裂症的治疗中,我们发现最常见的抗精神病药疗法使用,意思是口服和长效的可注射形式。患者大多接受抗精神单药治疗,但其复杂的效果补充了其他精神药物,主要是情绪稳定剂和抗焦虑。结论:我们的研究结果表明精神分裂症与医疗保健利用方面的悲伤之间的相似性,尽管悲伤一般认为是“较温和”的疾病。另一方面,该研究表明所用药物疗法谱的差异。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号